CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Correa, P.
Right arrow Articles by Schneider, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Correa, P.
Right arrow Articles by Schneider, B. G.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1865-1868, August 2005
© 2005 American Association for Cancer Research


Special Section

Etiology of Gastric Cancer: What Is New?

Pelayo Correa and Barbara G. Schneider

Department of Pathology, Louisiana State University Health Sciences Center and Stanley Scott Cancer Center, New Orleans, Louisiana

Requests for reprints: Pelayo Correa, Department of Pathology, Louisiana State University Health Sciences Center, 1901 Perdido Street, Box P5-1, New Orleans, LA 70112. Phone: 504-568-6035; Fax: 504-599-1278. E-mail: correa{at}lsuhsc.edu

Recent advances in understanding of risk factors for gastric cancer have focused attention on genetic polymorphisms in both the human host and in Helicobacter pylori. Variation in genes for cytokines such as interleukin-1ß and its receptor antagonist may allow identification of those individuals predisposed to mount an immune response that puts them at elevated risk for gastric cancer. Likewise, analysis of how genetic variation in the genome of H. pylori may modulate the action of virulence factors like CagA may prove useful in identification of persons for whom H. pylori eradication efforts would be most important. This review examines recent studies on interleukin-1ß polymorphisms and H. pylori CagA variation with respect to their modulation of risk for gastric cancer.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
S. Boccia, R. Hung, G. Ricciardi, F. Gianfagna, M. P. A. Ebert, J.-Y. Fang, C.-M. Gao, T. Gotze, F. Graziano, M. Lacasana-Navarro, et al.
Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review
Am. J. Epidemiol., March 1, 2008; 167(5): 505 - 516.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. E. Vollset, J. Igland, M. Jenab, A. Fredriksen, K. Meyer, S. Eussen, H. K. Gjessing, P. M. Ueland, G. Pera, N. Sala, et al.
The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2416 - 2424.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.